Oslo, 12 December 2025 - Observe Medical ASA (the "Company" or "Observe
Medical") announces expansion of portfolio, progress on commercial journey and
in the development of UnoMeterT SafetiT Max.
The Company is launching an extension of its portfolio of products within the
category of Urological Drainage. The launch includes 3 new products: a front
mounted UnoMeter which is a preference in some markets and 2 Closed System
products which are sterile solutions used widely within hospitals globally. In
combination it is estimated the global market value of these products are at a
level of 1,6-1,8 bill. NOK.
Jørgen Mann, CEO of Observe Medical, commented: "We have a strong distribution
platform with a wide geographical reach and it is a logical step to introduce an
extended range which will give us access to a global market which has a market
value of more than 1,5 bill. NOK. The new products, which are part of the same
category as the UnoMeter's, will give us additional growth potential and we can
now offer a more complete range in the category of Urological Drainage which
will offer extended value to both our distributors and the hospitals."
The Company sees continued positive development as the market penetration
continues and we are continuously seeing additional hospital and contract wins
in many markets including the Spanish, German, Swiss and Portuguese markets.
The development of UnoMeterT SafetiT Max continues to be on track with
manufacturing capabilities being established, certification preparation
progressing and we have seen the first positive results on the clinical
performance of the product.
For further information, please contact:
Jørgen Mann, CEO Observe Medical
Mobile: +45 408 67558
E-mail: jorgen.mann@observemedical.com
Johan Fagerli, CFO Observe Medical
Mobile: +47 958 12765
E-mail: johan.fagerli@observemedical.com
About Observe Medical
Observe Medical is a Nordic medtech company that develops, markets and sells
innovative medtech products for the global market. The Company is committed to
improving patient welfare and patient outcomes, improving clinical data accuracy
and promoting positive health economics.
The Company seeks to drive growth by leveraging its expertise in sales and
commercialization of its broad portfolio of medical technology products, mainly
in urine measurement and ultrasound, in combination with targeted M&A and
distribution. Observe Medical is working with a network of leading distributors
to provide outstanding solutions for healthcare professionals globally.
The Company is headquartered in Oslo, Norway.
Further information is available atwww.observemedical.com.